Research published by Joe Zorek, assistant professor (CHS) in the Pharmacy Practice Division, and colleagues, entitled “A comparison of the validity of two instruments assessing health professional student perceptions of interprofessional education and practice,” was …
Alissa Hofer, a fourth year Doctor of Pharmacy student, was the lead author in a study exploring pharmacists’ role in addressing the opioid epidemic. Hofer collaborated with addiction medicine experts in the UW Department of …
Betty Chewning, professor and Apple Distinguished Chair in the Social and Administrative Sciences Division, served as a member of the Study Team for the University of North Carolina Eshelman School of Pharmacy
Olayinka Shiyanbola, assistant professor in the Social and Administrative Sciences Division, is among the invited presenters for the 8th Patient Adherence and Access Summit to be held in Philadelphia in March.
Barry Gidal, professor (CHS) and Chair, Pharmacy Practice Division, was among the inaugural group of individuals to receive the Fellow of the American Epilepsy Society (FAES) credential.
Eva Vivian, professor (CHS) in the Pharmacy Practice Division, was awarded the 2016 Distinguished Community Award from the Madison Chapter of The Links.
Pharmacogenetics and predictive prescribing was the topic addressed by Larisa H. Cavallari, PharmD, BCPS, FCCP, Associate Professor and Associate Chair Department of Pharmacotherapy and Translational Research Director, Center for Pharmacogenomics,
Representing the Social and Administrative, and Pharmaceutical Sciences Divisions, several PhD candidates prepare to simultaneously defend their thesis and identify the next step in their education or career journey.
Michelle Chui, associate professor and vice chair in the Social & Administrative Sciences Division, and director of the Systems Approach to Medication Safety (SAMS) Research Laboratory, has been selected 2017-2018 chair-elect of the American Pharmacists …
Barry Gidal, professor (CHS) and Chair, Pharmacy Practice Division, presented a plenary session at an international epilepsy conference held in Cuba. Entitled “Advances in the Treatment of Epilepsy: Does Mechanism of Action matter?,” Gidal’s presentation